| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/14/1997 | WO1997028816A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| 08/14/1997 | WO1997028813A1 Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
| 08/14/1997 | WO1997028811A1 Use of arabinogalactan in a sperm wash product |
| 08/14/1997 | WO1997028808A1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 08/14/1997 | WO1997028807A1 Anticancer substance suppressing cancerous metastasis |
| 08/14/1997 | WO1997028806A1 Treatment for hypercholesterolemia |
| 08/14/1997 | WO1997028805A1 Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound |
| 08/14/1997 | WO1997028804A1 Granules from triazines |
| 08/14/1997 | WO1997028803A1 Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits |
| 08/14/1997 | WO1997028802A1 Inhibition of viral replication |
| 08/14/1997 | WO1997028801A1 Colonic delivery of nicotine to treat inflammatory bowel disease |
| 08/14/1997 | WO1997028800A1 Use of thiazolidine derivatives to prepare drugs for treating drugs abuse |
| 08/14/1997 | WO1997028799A1 Application of pyrrolidine derivatives to the preparation of medicaments for the treatment of drug abuse |
| 08/14/1997 | WO1997028798A1 Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse |
| 08/14/1997 | WO1997028797A1 Method of treatment and pharmaceutical composion |
| 08/14/1997 | WO1997028796A1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 08/14/1997 | WO1997028795A1 Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections |
| 08/14/1997 | WO1997028794A1 Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
| 08/14/1997 | WO1997028793A1 External preparation containing tranilast and process for producing the same |
| 08/14/1997 | WO1997028792A1 Traitement and prevention of adverse effects of reactive oxygen species |
| 08/14/1997 | WO1997028791A1 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 08/14/1997 | WO1997028786A1 Composition and method for effecting superficial chemical skin peels |
| 08/14/1997 | WO1997028784A1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
| 08/14/1997 | WO1997021801A3 Production and screening process for phytochemical production by plant cell cultures |
| 08/14/1997 | WO1997020550A3 Improved method for preventing crystal formation in a dispersion of a liquid in a matrix |
| 08/14/1997 | WO1997015293A3 Method of producing multi-layer medicaments in solid form for oral or rectal administration |
| 08/14/1997 | WO1997014679A3 Method of detecting cyclooxygenase-2 |
| 08/14/1997 | WO1997013489A3 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 08/14/1997 | DE19606897A1 Agent inhibiting tumour cell spread and metastasis in surgery of tumours |
| 08/14/1997 | DE19606355A1 Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung Contraceptive delivery systems with antiviral and / or antibacterial effect |
| 08/14/1997 | DE19605126A1 Thrombinmuteine als Antidot für Thrombininhibitoren Thrombin muteins as an antidote for thrombin inhibitors |
| 08/14/1997 | DE19605105A1 Neue Sonde zur Früherkennung von epithelialen Dysplasien des mehrschichtigen Plattenepithels sowie zur Tumordiagnostik und Tumortherapie von Plattenepithelkarzinomen New probe for early detection of epithelial dysplasia of the stratified squamous epithelium as well as for tumor diagnosis and tumor therapy of squamous cell carcinoma |
| 08/14/1997 | DE19604773A1 Regulierung der Spermatogenese Regulation of spermatogenesis |
| 08/14/1997 | DE19604744A1 Technische Di-/Triglyceridgemische Technical di- / triglyceride |
| 08/14/1997 | DE19603018A1 Kosmetisches Selbstbräunungsmittel mit Lichtschutzwirkung Cosmetic self-tanning product with sun protection |
| 08/14/1997 | CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 08/14/1997 | CA2246321A1 New cephem compounds and pharmaceutical use thereof |
| 08/14/1997 | CA2245925A1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
| 08/14/1997 | CA2245920A1 Contraceptive release systems with antibacterial and/or antiviral effect |
| 08/14/1997 | CA2245836A1 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 08/14/1997 | CA2245783A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | CA2245546A1 Thrombin muteins as antidotes for thrombin inhibitors |
| 08/14/1997 | CA2245508A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
| 08/14/1997 | CA2245170A1 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | CA2245162A1 Method of treatment and pharmaceutical composition |
| 08/14/1997 | CA2244901A1 Micacocidin derivatives |
| 08/14/1997 | CA2244848A1 Inhibition of viral replication |
| 08/14/1997 | CA2244812A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 08/14/1997 | CA2244792A1 Recombinant phages |
| 08/14/1997 | CA2244745A1 Histamine h3 receptor ligands |
| 08/14/1997 | CA2244708A1 Novel cyclic amino acids as pharmaceutical agents |
| 08/14/1997 | CA2244110A1 Novel methods of vaccination and vaccines thereof comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/14/1997 | CA2242245A1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 08/14/1997 | CA2241551A1 Coralyne analogs as topoisomerase inhibitors |
| 08/14/1997 | CA2217008A1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 08/14/1997 | CA2199615A1 Erythro-hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemia traits |
| 08/13/1997 | EP0789026A1 Hetero-aryl oxazolidinone and their use as antibacterial medicine |
| 08/13/1997 | EP0789025A1 Substituted oxazolidinone and their use as antibacterial medicine |
| 08/13/1997 | EP0789021A1 Hydroxamic acid compounds as opioid kappa receptor agonists |
| 08/13/1997 | EP0788801A1 Sustained-release oral ointment |
| 08/13/1997 | EP0788798A1 Antiviral agent and process for preparing the same |
| 08/13/1997 | EP0788797A1 Use of PHMB for the treatment of infections caused by intracellularly propagating germs |
| 08/13/1997 | EP0788796A1 Uricosuric agent |
| 08/13/1997 | EP0788795A1 Pharmacologically active 2-mercaptobenzimidazole derivatives |
| 08/13/1997 | EP0788794A1 Composition of external preparation |
| 08/13/1997 | EP0788793A1 Idebenone for the treatment of dementia |
| 08/13/1997 | EP0788792A1 Matrix type patch preparation |
| 08/13/1997 | EP0788789A1 Ranitidine compositions and their use for the treatment of minor gastrointestinal disorders associated with excess acid secretion |
| 08/13/1997 | EP0788515A1 Non-antigenic branched polymer conjugates |
| 08/13/1997 | EP0788511A1 Cyclic hexapeptides having antibiotic activity |
| 08/13/1997 | EP0788507A1 L-pyranosyl nucleosides |
| 08/13/1997 | EP0788506A2 L-ribofuranosyl nucleosides |
| 08/13/1997 | EP0788503A1 Novel quinoxalindione derivatives, their production and use in medicaments |
| 08/13/1997 | EP0788501A1 Protein kinase inhibitors for treatment of neurological disorders |
| 08/13/1997 | EP0788499A1 Cns-active pyridinylurea derivatives |
| 08/13/1997 | EP0788498A1 Phenyloxazolidinone antimicrobials |
| 08/13/1997 | EP0788497A1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 08/13/1997 | EP0788496A1 Apolipoprotein-b synthesis inhibitors |
| 08/13/1997 | EP0788495A2 L-erythrosyl nucleosides |
| 08/13/1997 | EP0788493A1 Taxoid derivatives, their preparation and their use as antitumor agents |
| 08/13/1997 | EP0788492A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 08/13/1997 | EP0788491A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives |
| 08/13/1997 | EP0788490A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 08/13/1997 | EP0788489A1 Heterocyclic compounds and their use |
| 08/13/1997 | EP0788487A1 Process for the preparation of tetrazoles |
| 08/13/1997 | EP0788483A1 7-substituted 4-aza cholanic acid derivatives and their use |
| 08/13/1997 | EP0788478A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 08/13/1997 | EP0788476A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors |
| 08/13/1997 | EP0788474A1 Nitro-benzamides useful as anti-arrhythmic agents |
| 08/13/1997 | EP0788383A2 Modulation of cell proliferation and wound healing |
| 08/13/1997 | EP0788373A1 Novel complexes and their compositions |
| 08/13/1997 | EP0788369A1 AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF |
| 08/13/1997 | EP0788368A1 Therapeutic composition for replacing and/or supplementing body fluids |
| 08/13/1997 | EP0788367A1 Stretch-activated cation channel and antisense oligonucleotides thereto |
| 08/13/1997 | EP0788366A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 08/13/1997 | EP0788365A1 Use of 2',5'-oligoadenylates for treatment of papillomatoses |
| 08/13/1997 | EP0788364A1 Treatment of urogenital cancer with boron neutron capture therapy |
| 08/13/1997 | EP0788363A1 Novel medicinal use |
| 08/13/1997 | EP0788362A1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |